These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7366286)

  • 1. [Hyperlipidemia and atheroscolerosis in patients with chronic renal failure in hemodialysis].
    del Rio Vázquez A; Rico Lenza H
    Med Clin (Barc); 1980 Mar; 74(6):239-43. PubMed ID: 7366286
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in cholesterol transport by lipoproteins in patients with renal insufficiency].
    Pérez A; Alegre B; Panadero J; Martín L; Breto M; Cruz JM
    Rev Clin Esp; 1983 Jan; 168(1):13-6. PubMed ID: 6844674
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary risk in patients with endstage renal disease: interaction of hypertension with hyperlipidemia.
    Goldberg AP; Tindira C; Harter HR
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S257-61. PubMed ID: 6177969
    [No Abstract]   [Full Text] [Related]  

  • 4. [Causes and risks of hyperlipidemia during dialysis and after renal transplantation].
    Verzola A; Perini L; Gatto S; Gilli P; Bedani PL
    Recenti Prog Med; 1998 Nov; 89(11):590-7. PubMed ID: 9844447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid metabolism abnormalities and atherosclerosis in patients on maintenance hemodialysis].
    Musiał J; Undas A; Sysło K
    Przegl Lek; 1994; 51(6):264-7. PubMed ID: 7938663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic kidney failure, hyperproteinemia and vascular risk].
    Rubiés-Prat J
    Med Clin (Barc); 1984 Jun; 83(4):173-5. PubMed ID: 6482569
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid metabolism disorders in patients with chronic renal failure].
    Zdrojewski Z
    Pol Tyg Lek; 1982 May; 37(13):391-3. PubMed ID: 7134045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid metabolism disorders in patients with chronic kidney failure].
    Lutz W
    Postepy Hig Med Dosw; 1977; 31(2):263-83. PubMed ID: 18726
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of dyslipidemia of chronic renal failure.
    Vaziri ND; Moradi H
    Hemodial Int; 2006 Jan; 10(1):1-7. PubMed ID: 16441821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atherosclerosis and hypertriglyceremia in chronic renal failure].
    Lutz W
    Pol Tyg Lek; 1976 Jun; 31(25):1089-91. PubMed ID: 181736
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of magnesium and lipid disturbances in chronic renal failure].
    Fijałkowska-Morawska J; Chrzanowski W
    Pol Arch Med Wewn; 1997 Oct; 98(10):327-31. PubMed ID: 9557087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
    Gugliucci A; Lunceford N; Kinugasa E; Ogata H; Schulze J; Kimura S
    Clin Chim Acta; 2007 Sep; 384(1-2):105-12. PubMed ID: 17632094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
    Nishizawa Y; Shoji T; Kawagishi T; Morii H
    Kidney Int Suppl; 1997 Nov; 62():S90-2. PubMed ID: 9350691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis.
    Schulz T; Schiffl H; Scheithe R; Hrboticky N; Lorenz R
    Am J Kidney Dis; 1995 Apr; 25(4):564-71. PubMed ID: 7702051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal dyslipidemia in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(3-4):77-80. PubMed ID: 12899098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.